A2Bio logo
A2Bio logo

A2Bio

a2bio.com
a2bio.com • HQ: Agoura Hills, United States • Venture - Series Unknown 2022 • Founded 2017
HQ: Agoura Hills, United States • Venture - Series Unknown 2022 • Founded 2017
Cell & Gene Therapy
Health Care
Oncology Therapeutics
Claim pageClaim
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials

Visa sponsorship

  • United States · H-1B filings in 12 months: 1 · green card filings: 1

Visa details by country

Overview

A2 is dedicated to advancing cancer treatment through pioneering cell therapy. Our T cells target solid tumors with precision, transforming the future of medicine.

People

Scott Foraker
Executive Officer, Director
SEC Form D
David Lucas
Executive Officer
SEC Form D
William Go
Executive Officer
SEC Form D
Thomas Leung
Executive Officer
SEC Form D
Alexander Kamb
Executive Officer, Director
SEC Form D
Srini Akkaraju
Director
SEC Form D
Madhavan Balachandran
Director
SEC Form D
Michael Gallo
Director
SEC Form D
David Goeddel
Director
SEC Form D
C. Kamb
Director
SEC Form D
Helen Kim
Director
SEC Form D
Jakob Loven
Director
SEC Form D
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Agoura Hills United States
HQ
General Inquiries
30301 Agoura Road #210, Agoura Hills, CA 91301
company site

Financials

Total raised
$143.1M
Latest round
Venture - Series Unknown
Funding rounds
2
Funding rounds
Round Announced Amount
Venture - Series Unknown 2022 $71.6M Details
Venture - Series Unknown 2020 $71.5M Details